Menu
ÚHKT

Impaktované publikace

[1]

Machova Polakova, K.; Zizkova, H.; Zuna, J.; Motlova, E.; Hovorkova, L.; Gottschalk, A.; Glauche, I.; Koblihova, J.; Pecherkova, P.; Klamova, H.; Stastna Markova, M.; Srbova, D.; Benesova, A.; Polivkova, V.; et al.

Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission

[rok vydání 2020, impact factor 11.528 ]

[2]

Srutova, K.; Curik, N.; Burda, P.; Savvulidi, F.; Silvestri, G.; Trotta, R.; Klamova, H.; Pecherkova, P.; Sovova, Z.; Koblihova, J.; Stopka, T.; Perrotti, D.; Machova Polakova, K.

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia

[rok vydání 2018, impact factor 7.570 ]

[3]

Šálek, C.; Folber, F.; Froňková, E.; Pecherková, P.; Jelínková, H.; Hrabovský, Š.; Horáček, J.M.; Cetkovský, P.; Mayer, J.; Trka, J.; Doubek, M.

Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant

[rok vydání 2021, impact factor 6.998 ]

[4]

Szikszai, K.; Krejcik, Z.; Klema, J.; Loudova, N.; Hrustincova, A.; Belickova, M.; Hruba, M.; Vesela, J.; Stranecky, V.; Kundrat, D.; Pecherkova, P.; Cermak, J.; Jonasova, A.; Dostalova Merkerova, M.

LncRNA profiling reveals that the deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 is associated with higher-risk myelodysplastic syndrome

[rok vydání 2020, impact factor 6.639 ]

[5]

Hrustincova, A.; Krejcik, Z.; Kundrat, D.; Szikszai, K.; Belickova, M.; Pecherkova, P.; Klema, J.; Vesela, J.; Hruba, M.; Cermak, J.; Hrdinova, T.; Krijt, M.; Valka, J.; Jonasova, A.; Merkerova, M.D.

Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome

[rok vydání 2020, impact factor 6.600 ]

[6]

Jaruskova, M.; Curik, N.; Hercog, R.; Polivkova, V.; Motlova, E.; Benes, V.; Klamova, H.; Pecherkova, P.; Belohlavkova, P.; Vrbacky, F.; Machova Polakova, K.

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment

[rok vydání 2017, impact factor 6.217 ]

[7]

Šťastná Marková, M.; Hamšíková, E.; Hainz, P.; Hubáček, P.; Kroutilová, M.; Kryštofová, J.; Ludvíková, V.; Musil, J.; Pecherková, P.; Saláková, M.; Šroller, V.;

Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk of BK virus-associated haemorrhagic cystitis after allogeneic HSCT

[rok vydání 2021, impact factor 4.422 ]

[8]

Šestáková, Š.; Krejčík, Z.; Folta, A.; Cerovská, E.; Šálek, C.; Dostálová Merkerová, M.; Pecherková, P.; Ráčil, Z.; Mayer, J.; Cetkovský, P.; Remešová, H.

DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations

[rok vydání 2019, impact factor 3.436 ]

[9]

Pecankova, K.; Pecherkova, P.; Gasova, Z.; Sovova, Z.; Riedel, T.; Jäger, E.; Cermak, J.; Majek, P.

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome

[rok vydání 2022, impact factor 3.240 ]

[10]

Kuželová, K.; Brodská, B.; Schetelig, J.; Röllig, C.; Ráčil, Z.; Stickel Walz, J.; Helbig, G.; Fuchs, O.; Vraná, M.; Pecherková, P.; Šálek, C.; Mayer, J.

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin

[rok vydání 2018, impact factor 2.776 ]

[11]

Vydra, J.; Šálek, C.; Schwarz, J.; Žák, P.; Novák, J.; Petečuková, V.; Pecherková, P.; Mayer, J.; Cetkovský, P.; Ráčil, Z.

Analysis of real-world data on postremission therapy for acute myeloid leukemia with intermediate risk cytogenetics in first complete remission

[rok vydání 2017, impact factor 2.274 ]

[12]

Vrana, M.; Siffnerova, V.; Pecherkova, P.; Ratajova, E.; Sonka, K.

Distribution of HLA-DQB1 in Czech patients with central hypersomnias

[rok vydání 2017, impact factor 2.040 ]

[13]

Ptackova, P.; Petrackova, M.; Hindos, M.; Duskova, M.; Hamsikova, E.; Klamova, H.; Pecherkova, P.; Humlova, Z.; Vonka, V.

Intracellular cytokines produced by stimulated CD3+ cells from chronic myeloid leukemia patients

[rok vydání 2017, impact factor 1.307 ]